Prediction: U.S. Small-Cap Stocks Will Beat Large Caps for 10 Years

This is less a broad “small caps” call than a factor-quality call. If the rotation persists, the best relative winners are balance-sheet-clean domestic names with operating leverage to easier financial conditions; the weakest are levered, cash-burning micro/small caps that only screen cheap on trailing multiples. That argues for selective exposure to high-quality value/industrial/consumer names in the small-cap universe, while avoiding the idea that every constituent gets the same benefit.

The first-order move can be flow-driven and self-reinforcing because small-cap ETFs are still the easiest way for allocators to express the trade. But the deeper catalyst is rates: small caps only keep outperforming if real yields drift lower and credit stays open. If financing spreads widen or Treasury yields back up, the levered half of the basket will underperform quickly, even if the headline factor remains popular.

Consensus is likely overweighting valuation and underweighting earnings dispersion. The market may already be paying for a “small-cap rebound,” but the alpha is in the composition: cleaner value names and profitable cyclicals should outperform the generic index, while biotech and other duration-sensitive stories are exposed to any macro wobble. The thesis is falsified if 10Y yields re-accelerate or high-yield spreads start widening over the next 1-3 months, because that would mechanically compress small-cap multiples and force weaker names to reprice faster than the index.